Walgreens delivered a second fiscal quarter better than expected and a smaller loss per month after announcing that it would be bought by a investment capital company.
The chain of pharmacies has reserved sales of pharmacies sales and its company from the Villagemd clinic in difficulty delivered a smaller assessment during the recently finished quarter.
Overall, Walgreens said on Tuesday that it had lost $ 2.85 billion compared to a loss of $ 5.91 billion in the quarter of the previous year. The adjusted results do not count the occasional elements have totaled 63 cents per share during the last quarter. Sales increased by 4% to 38.59 billion dollars.
From 12:20:57 pm Edt. Market open.
Analysts expected a budgetary budgetary benefit of 53 cents per share out of approximately $ 38 billion in revenues, according to the data company FOTSET.
Walgreens said in March that it had agreed to be acquired by the Sycamore Partners in an agreement with an agreement with an equity value of just under $ 10 billion.
The acquisition came while the pharmacy chain deals with several problems, including reimbursement of the thin prescription, the cost increase and a company from the Villagemd clinic which had trouble gaining ground with the patients.
Deerfield, Illinois, reduces the costs and closure of stores. In January, he said that he suspended a quarterly dividend which he had offered for over 90 years.
During his second tax quarter, sales of American pharmacies established by Walgreens jumped 12%, helped in part by more prescriptions. But retail sales in these stores have slipped around 3%.
Walgreens Boots Alliance Inc. also manages nearly 3,700 international stores, with locations in the United Kingdom, Mexico, Thailand and Ireland. The American segment is most of its activities.
During the recent quarter, Walgreens said that his operating loss included an unconventional disability burden of $ 3 billion linked in part to its Villagemd activity. This is compared to a charge of more than $ 12 billion in the quarter of the previous year.
Walgreens withdrew its annual forecasts because of its pending agreement and did not organize a conference call with analysts to discuss the results.
The actions of the company increased from 19 cents to $ 10.90 Tuesday morning while market indices organized a larger rally against losses on Monday.
